TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SOFGEN PHARMS

Pharmaceuticals
Generics

SOFGEN PHARMS is a generic drug manufacturer with 4 FDA-approved products.

2012
Since
4
Drugs
-
Trials
53
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PROGESTERONE 2025-09-19
IBUPROFEN 2025-04-29
Manufacturing (CMC)
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-03-20
Manufacturing (CMC)
PROGESTERONE 2025-03-03
Labeling
PROGESTERONE 2025-03-03
Labeling
NIMODIPINE 2025-01-22
IBUPROFEN 2024-11-21
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...